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Background: The Manchester Foot Pain and Disability Index (MFPDI, 19 items) was developed to measure
functional limitations, pain and appearance for patients with foot pain and is frequently used in both observational
studies and randomised controlled trials. A Dutch version of the MFPDI was developed. The aims of this study were
to evaluate all the measurement properties for the Dutch version of the MFPDI and to evaluate comparability to
the original version.
Method: The MFPDI was translated into Dutch using a forward/backward translation process. The dimensionality
was evaluated using exploratory and confirmatory factor analysis. Measurement properties were evaluated per
subscale according to the COSMIN taxonomy consisting of: reliability (internal consistency, test-retest reliability and
measurement error), validity (structural validity, content validity and cross-cultural validity comparing the Dutch
version to the English version) responsiveness and interpretation.
Results: The questionnaire consists of three scales, measuring foot function, foot pain and perception. The reliability
of the foot function scale is acceptable (Cronbach’s α > 0.7, ICC = 0.7, SEM = 2.2 on 0-18 scale). The construct
validity of the function and pain scale was confirmed and only the pain scale contains one item with differential
item functioning (DIF). The responsiveness of the function and pain scale is moderate when compared to anchor
questions.
Conclusion: Results using the Dutch MFPDI version can be compared to results using the original version. The
foot function sub-scale (items 1-9) is a reliable and valid sub-scale. This study indicates that the use of the MFPDI
as a longitudinal instrument might be problematic for measuring change in musculoskeletal foot pain due to
moderate responsiveness.Background
Foot pain is common in older people and is associated
with functional limitations in foot related activities; prev-
alences between 14.9 and 41.9% have been reported in
people over 50 years [1-6]. The Manchester Foot Pain
and Disability Index (MFPDI) is a 19 item tool devel-
oped to measure foot pain and foot related function in
patients with foot pain [7]. It intends to measure 3 con-
structs: functional limitation, pain and personal appear-
ance [7]. Statements relating to the 3 constructs can be
answered in terms of frequencies: ‘none of the time’, ‘on* Correspondence: b.vanderzwaard@vumc.nl
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distribution, and reproduction in any mediumsome days’ and ‘on most/every day(s)’. Previous studies
have evaluated some of the measurement properties of
the questionnaire. Internal consistency (IC) is the most
evaluated property [7-12] although some studies evaluated
it over the entire questionnaire instead of over the three
constructs (i.e. sub-scales) [7,9,10]. The studies that did
evaluate each sub-scale separately have found the scales to
be internal consistent [8,12]. Test-retest reliability has
been analysed by Roddy et al. [12] and found to be mod-
erate for the pain and the appearance scale and both
moderate and acceptable for the functional limitations
scale depending on the inclusion criterion. Construct
validity has been described in previous studies although
the amount of hypotheses tested was small in one study
[7] and no hypotheses were stated a priori in another [10].
The characteristics of the items in the questionnaire haveCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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testing (IRT). The MFPDI consists of items that allow
severe cases to be distinguished from the less severe
cases [8,11].
The MFPDI is not merely a descriptive tool (e.g. in
cross-sectional studies) but it is also used as a tool to
measure change over time as a result of an intervention
[13-15]. When interpreting change scores in a randomised
controlled trial (RCT) or another longitudinal study, it is
vital to have knowledge about measurement properties
like measurement error, responsiveness and interpretation
values like minimal important change (MIC) and smallest
detectable change (SDC). Currently these properties have
not been assessed yet. For the purpose of a Dutch study
on forefoot pain in people 50 years of age or older the
MFPDI had to be translated into Dutch [15]. The aims of
the current study are, firstly, to create a Dutch version of
the MFPDI. Secondly, to evaluate measurement properties
based on the Classical Test Theory (CTT), including a
cross-cultural validation of the Manchester Foot Pain and
Disability Index using the Dutch translated version.
Method
This study describes an evaluation of measurement prop-
erties of the MFPDI starting with the translation of the
questionnaire into Dutch. The Medical Ethics Committee
of the VU University Medical Centre in Amsterdam has
approved the design of this study (No. 2009/267).
Translation
A forward-backward method of translation was used to
obtain a Dutch version of the MFPDI [16]. Two trans-
lators; a general practitioner and a physical education
teacher, both with additional experience with English,
translated the original version into Dutch. During the
consensus meeting with the two translators and guided
by PE and BvdZ, a consented Dutch version was estab-
lished. This version was then translated back into English
by two native speakers; a UK scientific researcher and a
UK physician assistant. Differences between the original
and the translated version were discussed by BvdZ and
PE and the Dutch version was accordingly adapted.
The Dutch version was then tested by 10 participants,
who were asked about intelligibility and completeness
of the list. Concerns identified regarding intelligibility
and completeness were discussed between BvdZ and
PE and adapted if required.
Participants
As part of an RCT that compares treatment of forefoot
pain by means of podiatric care or shoe advice, participants
aged 50 years and over with non traumatic forefoot pain
that lead to functional limitations were recruited [15]. Ex-
clusion criteria were: the presence of diabetic neuropathy,non musculoskeletal foot pain (e.g. warts) or pain caused
by rheumatoid arthritis. Participants had to be able to walk
un-assisted for 7 metres. These participants completed the
MFPDI on multiple occasions during the trial as part of
self administered questionnaires. The MFPDI was used as
a screening tool; participants had to score at least one item
on the MFPDI as occurring ‘on most/every day(s)’ to
be considered limited functionally and thus eligible for
the trial.
Procedure and outcome measures
Preceding inclusion the MFPDI was used as a screening
tool (NL Ts). One to three weeks later the participants
were included in the trial and completed a comprehen-
sive questionnaire with the below mentioned comparator
instruments and the MFPDI as a baseline measurement
(NL T0). Since all participants had at least 3 months of
foot pain and were considered to have limited function-
ality indicating a stable state no additional measures
were taken to assess possible changes between baseline
and screening. Three months after baseline a similar
questionnaire was completed again (NL T3). The lowest
response in the MFPDI was marked as 0 and the highest
response as 2. The COSMIN taxonomy was utilized to
evaluate every measurement property of the MFPDI
questionnaire [17,18].
As comparator instruments to the MFPDI several
other questionnaires were completed: the Foot Function
Index-5 pt [19] (FFI-5 pt), SF12® and an 11 point pain
intensity numeric rating scale (NRS where 0 = no pain
and 10 = worst possible pain). The FFI-5 pt is a question-
naire on foot function, consisting of two subscales: foot
pain and foot related activities, consisting of respectively 7
and 8 items. The original FFI is more extensive (23 items),
has response options using visual analogue scales (VAS)
and was developed for people with rheumatoid arthritis.
The FFI-5 pt has been validated for use in the elderly with
non rheumatic foot problems, has 5 response options
(ranging from “no pain” to “intense pain” and from “no
difficulty” to “impossible”) and has already been translated
into Dutch [19]. In addition to the comparator instru-
ments and the MFPDI, two global perceived effect (GPE)
questions on foot pain and foot related disability were
added to the NL T3 questionnaire: “How would you judge
the pain in your foot now, compared to three months
ago?” and “How would you judge the performance of foot
related activities now, compared to three months ago?”.
These GPE questions could be answered with: “much
worse, worse, no change, better or much better”.
UK sample for cross-cultural validation
For the purpose of assessing cross-cultural validity, a
sub-sample of data was obtained from two phases of the
North Staffordshire Osteoarthritis Project (NorStOP)
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50 years and over registered with six general practices
in North Staffordshire, UK. Briefly, NorStOP consisted
of a two-stage cross-sectional questionnaire. Stage 1
consisted of a postal Health Survey questionnaire. Re-
spondents to this questionnaire who reported experien-
cing foot pain in the last 12 months were sent a Regional
Pain Survey questionnaire which contained the MFPDI.
Respondents were also asked to provide consent for
review of their medical records.
Criteria for inclusion in the sub-sample for this analysis
were: having foot pain in the last 12 months, reporting at
least 2 items on the MFPDI occurring on “some days”
or “most/every day(s)”, and both providing consent to
medical record review and consulting their GP with
musculoskeletal foot problems in the 18 months prior
to the baseline Health Survey. Participants who had dia-
betes mellitus (self-report in Health Survey questionnaire)
or had consulted their GP for rheumatoid arthritis in
the 18 months prior to the baseline Health Survey were
excluded.
Statistical analyses
First, the dimensionality of the Dutch version of the
MFPDI was investigated using an exploratory factor ana-
lysis (EFA). A confirmatory factor analysis (CFA) was
used to evaluate the fit of the 3 construct conceptual
model [7,11,12] on the Dutch data. CFA was also used
to test both the 3 construct conceptual model and the
EFA findings on the UK data. The last two items of the
MFPDI (“I am unable to carry out my previous work”
and “I no longer do all my previous activities”) were not
applicable for a large number of participants (39%) and
were thus not used for either analyses. Model fit was
evaluated by comparing Root Mean Square Error of Ap-
proximation (RMSEA), Comparative Fit Index (CFI) and
Tucker-Lewis fit Index (TLI) from the two different
models. RMSEA ≤0.06 indicated good model fit and for
CFI and TLI a cut off value of 0.95 was chosen [23,24].
Reliability
Internal consistency (IC) IC was evaluated per sub-scale
of the NL T0 data using Cronbach’s α. An outcome be-
tween 0.7-0.95 was considered acceptable [25].
Test-retest reliability
To evaluate test-retest reliability, the intra class correl-
ation (ICCagreement) was calculated comparing the NL Ts
to the NL T0 data. Variance components were estimated
using the VARCOMP tool in SPSS. The ICCagreement was
calculated by dividing the variance between patients by
the sum of the variance between patients (σ2p ), the vari-
ance due to systematic differences between observations(σ20) and the residual variance (σ
2
residual) (equation 1) [26].
An ICC of 0.7 or higher was deemed acceptable [25].
ICCagreement ¼
σ2p
σ2p þ σ2o þ σ2residual
ð1Þ
Measurement error
The standard error of measurement (SEMagreement) was
calculated using the same variance components used for
the ICCagreement calculation (equation 2) [26], comparing






Construct validity In order to evaluate construct validity
the ‘hypotheses testing’ method was chosen in absence of
a gold standard [27]. Hypotheses were formulated based
on two general assumptions [27]. First, correlations be-
tween MFPDI subscales and (subscales of) similar ques-
tionnaires should be >0.50. Second, correlations between
MFPDI subscales and dissimilar questionnaires or sub-
scales should be lower. The following seven a priori de-
fined hypotheses stating expected correlations between
sub-scales of the MFPDI and the sub-scales of the FFI-
5pts, SF-12 and NRS within the NL T0 data were tested
using Pearson correlations:
1. The score of the MFPDI- function items (MFPDI-f )
correlates with the score of the FFI- 5pts function
items (FFI-f ) with R > 0.5;
2. The score of the MFPDI-f correlates with the score
of the SF12 physical function items (SF-12phys) with
R > 0.3;
3. R hypotheses 1 > R hypotheses 2;
4. The score of the MFPDI- pain items (MFPDI-p)
correlates with the score of the FFI- 5pts pain items
(FFI-p) with R > 0.5;
5. The score of the MFPDI-p correlates with the score
of the Pain Numeric Rating Scale (NRS-p) with
R > 0.5;
6. R of the MFPDI-f - SF-12 phys > R of the MFPDI-f - the
SF12 mental function items (SF-12ment);
7. R of the MFPDI-f - SF-12 phys > R of the
MFPDI-p - SF-12 phys.
The construct was deemed valid if 5 out of 7 hypotheses
were confirmed [25].
Cross-cultural validity
Differential Item Functioning Analyses (DIF analyses)
between NL T0 and UK NorStOP data using ordinal
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cultural validity. An IRT based model does not use ob-
served sub-scale scores but incorporates item difficulty
with sub-scale score providing an estimated score of the
latent trait (e.g. foot function, foot related pain); theta. A
negative theta implied a low dysfunction, a positive theta
more foot dysfunction. The responses to each item
(dependent variables) by Dutch and UK participants
with similar foot dysfunction were compared to evaluate
if country of origin (independent variable) significantly
affects the response [28]. An item displays DIF when pa-
tients with the same estimated theta on the sub-scale do
not have the same probability of endorsing that item.
There are two kinds of possible DIF: uniform and non-
uniform. Uniform DIF means that in one population an
item is endorsed less (or more) often at all values of
the construct, compared to the other population. Non-
uniform DIF means that in one population an item is
endorsed less (or more) often at some values of the
construct, but more (or less) often at other values of
the construct, compared to the other population. Non-
uniform and uniform DIF are comparable to respectively
effect modification and confounding in epidemiology. A
significant effect was present if more then 2% of the vari-
ance (R2) was due to country of origin. A uni-dimensional
construct could only be tested if the sub-scale consists
of at least five items, sub-scales with less items were not
analysed [29].
Responsiveness
In order to evaluate if the MFPDI was responsive to
change a construct approach was chosen by absence of a
gold standard. Change scores between the NL T0 and
NL T3 data were calculated. The following seven hy-
potheses comparing the change scores of the functional
limitation and pain sub-scales of the MFPDI to the change
scores of FFI-5pt, SF12 and the NRS and to the GPE ques-
tions using Pearsons correlation (p < 0.05):
1. The change score of the MFPDI- function items
(MFPDI-f ) correlates with the change score of the
FFI- 5pts function items (FFI-f ) with R > 0.5;
2. The change score of the MFPDI-f correlates with
the change score of the SF12 physical function items
(SF-12 phys) with R > 0.3;
3. The change score of the MFPDI-f correlates with
the GPE-function question with R > 0.5;
4. R hypotheses 1 > R hypotheses 2;
5. The change score of the MFPDI- pain items
(MFPDI-p) correlates with the change score of the
FFI- 5pts pain items (FFI-p) with R > 0.5;
6. The change score of the MFPDI-p correlates with
the change score of the Pain Numeric Rating Scale
(NRS-p) with R > 0.5;7. The change score of the MFPDI-p correlates with
the GPE-pain question with R > 0.5;
The questionnaire was deemed responsive when 5 out
of 7 hypotheses were confirmed [25].
Interpretability
A MIC was established using the visual anchor-based
MIC distribution method [30]. GPE scores were used to
calculate sensitivity and specificity at each possible cut-
off point for the changes in MFPDI scores between NL
T0 and NL T3; the MIC is the change score for which
the sum of proportion of misclassification is smallest
(i.e. (1-sensitivity) + (1-specificity)). A MIC was only cal-
culated if responsiveness hypotheses three and seven were
confirmed [30].
The SDC was calculated using the SEMagreement
(equation 3)




The calculated MIC has to be bigger than the SDC in
order for important change to be distinguishable from
measurement error in individual patients.
Lastly the presence of a floor or ceiling effect was eval-
uated within the NL T0 data. If 15% of the candidates
obtained the minimum or maximum sub-scale score a
respectively floor or ceiling effect was present [27].
Software
CFA and EFA were established using M + version 6.11.
The ‘lordif ’ package in R was used for analysis of cross-
cultural validity [28]. SPSS (IBM SPSS Statistics for
Windows, Version 20.0. Armonk, NY: IBM Corp.) was
used to evaluate the remaining measurement properties.
All measurement properties were evaluated for every
uni-dimensional sub-scale derived from the previous
mentioned EFA and CFA.
Results
Translation
Comparison of Dutch version of the questionnaire to the
original English version demonstrated four differences
that needed attention. The original item one states “I avoid
walking outside at all”, the “at all” was missing in the
Dutch and back translated version, and therefore ‘geheel’
was added to the statement. Item 2 (“I avoid walking long
distances”) was re-translated to: “I avoid walking longer
distances” (“Ik vermijd het lopen over langere afstand”).
After back translation this was changed into: “Ik vermijd
het lopen over lange afstanden” which back translates bet-
ter into the original version. The original item 10 states: “I
still do everything but with more pain or discomfort”.
After back translation “still” was missing; “nog steeds” was
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13: there is no literal Dutch word for “self-conscious”;
“negatief bewust” was our first choice which means: “nega-
tively aware”. After discussion during the back translation
we opted for: “verlegen” (“shy”) which in Dutch language
is closer to the original although it will be impossible to get
an exact translation. After pilot testing (n = 10) no more
changes where made to the Dutch version of the MFPDI.
Participants
The characteristics of the participants at screening, base-
line and three months for the Dutch (NL Ts, NL T0 and
NL T3) and the UK (UK NOrStOP; n = 370) participants
are presented in Table 1. The UK participants scored
significantly higher (p < 0.001) compared to the Dutch
participants on the severity of foot related disability and
foot pain (higher score indicates more disability or pain).
The Dutch participants scored significantly lower on
both the physical and mental components of the SF12
questionnaire (lower score indicates lower well-being).
Baseline characteristics of participants remaining in the
NL T3 (n = 178) and NL Ts (n = 195) do not differ sig-
nificantly from those in the NL T0 (n = 205). Ten NL Ts
were not used since the screening form was completed
on the same or previous day as completion of NL T0.
Missing values
The highest percentage of missing values per item of the
MFPDI is 2.4% (items 2, 13, 16). Combining the UK and
Dutch data for the DIF analyses for the cross cultural
validity item 3 had the highest percentage of missing
values: 2.8%. One participant in the UK data had more
than 50% missing values and this participant was excluded
from further analyses.
Factor analysis
Using EFA three sub-scales were found in NL T0 data: A
foot function scale (items 1-9), a pain scale (items 10,Table 1 Participant characteristics and item responses
NL Ts (n = 195)
Age: mean (SD) -
Gender (% Female) -
MFPDI sub-scale scores:
mean (SD)





SF 12 physical wellbeing -
SF 12 mental wellbeing -
-Data was not assessed or not applicable at this point in time.
*Significant difference p < 0.001 Chi square test comparing UK NOrStOP to NL T0.
**Significant difference p < 0.001 T-test comparing UK NOrStOP to NL T0.
***Significant difference p < 0.05 T-test comparing UK NOrStOP to NL T0.14-17) and a perception scale (items 11-13). Our factor
structure differed from the previously reported factor
structure [7,11,12] by the location of item 11 (‘I get irrit-
able when my feet hurt’). In our analysis it was included
in the perception scale whereas in previous studies it
was included in the functional limitations scale. Our
factor structure demonstrated the best fit in both data
sets (Table 2).
Reliability
Internal consistency The functional limitation sub-scale
was deemed to be internal consistent (Cronbach’s α > 0.7).
The internal consistency of the pain and perception
sub-scales were moderate (Table 3).
Test-retest reliability None of the ICC values reached
the generally accepted limit of 0.7 although the ICC for
the foot function sub-scale was 0.69 (Table 3).
Measurement error The SEM of the perception sub-
scale was large (36% of the maximum scale score). Both
the foot function and the foot pain scale contained a
smaller SEM; respectively 12% and 16% of the maximum
scale score.
Validity
Construct validity All a priori stated hypotheses about
correlations of the MFPDI function and pain scales to
the FFI-5pt, SF12 and NRS were confirmed (Table 2).
Cross cultural validity Due to the limited amount of
items (<5) in the perception sub-scale, DIF analysis was
not performed on this sub-scale. DIF analysis on the foot
function sub-scale showed that there was no DIF between
the UK and a Dutch population (Table 2). Item 17 in the
foot pain sub-scale (“I get shooting pain in my feet”)
showed uniform DIF. Having a similar level of foot pain
(theta), the Dutch population has a higher probability ofNL T0 (n = 205) NL T3 (n = 169) UK NOrStOP (n = 370)
64.1 (9.4) - 65.3 (9.4)
77.6% - *63%
6.2 (4.2) 5.0 (4.4) **9.7 (5.8)
4.8 (2.4) 3.6 (2.5) ***5.23 (2.6)
1.0 (1.2) 0.9 (1.2) **1.3 (1.4)
41.8 (6.8) 46.9 (2.4) **47.5 (11.6)
30.8 (9.7) 33.8 (4.6) **36.0 (11.9)
Table 2 Results of measurement properties related to: validity
Measurement
property
Research question Method Dataset(s) Results Interpretation
Structural validity
(Factor analysis)
Do the Dutch MFPDI and
the NorStOP MFPDI consist
of the same factor structure
(sub-scales) as the original?
ECA NL T0 Factors found: A slightly different factor
structure fitted better in
both data sets than the
previously reported factor
structure.
CFA n = 205 Functional construct:
1-9
UK NorStOP Pain construct: 10,
14-17






acceptable in the UK
dataset, but not in the
Dutch dataset.
RMSEA NL: 0.07 UK:0.05
CFI NL: 0.94 UK: 0.98
TLI NL: 0.93 UK: 0.98
Factor structure found
in this study:
RMSEA NL: 0.06 UK:0.04
CFI NL: 0.96 UK: 0.99
TLI NL: 0.96 UK: 0.99
Cross cultural
validity
Assuming a similar ‘true value’
for foot related disability, does
the Dutch population has the
same probability of endorsing
a certain response option on
the items of the MFPDI as




NL T0 Foot function
sub-scales: no DIF.
Assuming a similar ‘true
value’ for foot related
disability, the Dutch
population has a higher
probability of endorsing
the response option “none
of the time’” or “on some
days” on item 17 as
compared to the UK
population
n = 205 Foot pain sub-scale:
UK NorStOP Item 17 has DIF;
n = 365 R2 = 0.048
Theta for transition





Does the MFPDI relate to other
instruments as expected, based
on the study of Garrow et al. [7]
Pearsson Correlation* Comparator
instruments:
Pearsson Correlations: Construct validity is
accepted; all hypotheses
were confirmed.Testing 7 a priori
defined hypotheses:
1. Correlation MFPDI-f
and FFI-f (R > 0.5).




n = 205 2. R 0.31 (p < 0.000)*
3. R hypotheses 1 > R
hypotheses 2
3. R 0.66 > 0.0.31*
4. Correlation MFPDI-p
and FFI-p (R > 0.5)
4. R 0.60 (p < 0.000)*
5. Correlation MFPDI-p
and pain NRS (R > 0.5)
5. R 0.53 (p < 0.000)*
6. R MFPDI-f - SF-12
phys > R MFPDI-f -
SF12 ment
6. R 0.31 > R 0.14
(p = 0.045)*
7. R MFPDI-f - SF-12
phys > R MFPDI-p -
SF-12 phys




*MFPDI-f = MFPDI- function items, FFI-f = FFI- 5pts function items, SF-12 phys = SF12 physical function items, GPE-f = GPE-function question, MFPDI-p = MFPDI- pain
items, FFI-p = FFI- 5pts pain items, NRS-p = Pain Numeric Rating Scale, GPE-p = GPE-pain.
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Table 3 Results of measurement properties related to: reliability
Measurement
property
Research question Method Dataset(s) Results Interpretation





NL T0 Function: 0.84 The foot function scale is internally
consistent (>0.7). Internal consistency of
the other sub-scales is moderate.n = 205 Pain: 0.67
Perception: 0.61
Test-retest reliability Does the Dutch MFPDI
produce similar results when
completed repeatedly within





Function: 0.69 The test-retest reliability of the function
scale is nearly acceptable. Neither of the
other scales is reliable.




Which part of the variance is
due to measurement error?
SEM (per sub-scale) NL Ts and
NL T0
Function: 2.2 There are no set guidelines of what is
acceptable for the magnitude of SEM.
Function scale SEM of total score is:
12%, pain scale: 16%, perception: 36%n = 195 Pain: 1.6
Perception: 2.1
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Responsiveness
One of the 7 a priori stated hypotheses about correlations
between different change scores (change score = the differ-
ence between the scale score at NL T0 and NL T3) was
confirmed (Table 4). Neither the function scale nor the
pain scale change scores correlated to the corresponding
GPE questions at an acceptable level (respectively R = 0.46
and R = 0.47). These correlations were considered too low
to calculate a MIC.
Interpretability
The perception sub-scale showed an extreme floor effect;
86.2% of the participants obtained the minimum possible
scale score. The other sub-scales do not exhibit a floor or
ceiling effect (Table 4).
The SDC of the perception sub-scale is as large as the
maximum obtainable score of 6 points (Table 4). Due to
the inability to calculate a MIC, comparison of SDC and
MIC is not possible.
Discussion
Evaluation of the MFPDI measurement properties pro-
duced new useful information. Of the 3 uni-dimensional
sub-scales found in the NL T0 data only the functional
limitation sub-scale has an acceptable level of reliability.
Scores from the Dutch and UK version can be interpreted
similarly; only the pain subscale possesses one DIF item
but the differences in item responses and thus sub-scale
responses are smaller than the measurement error. The
responsiveness of the questionnaire is moderate.
Several studies have investigated the presence of sub-
scales within the MFPDI using either EFA and/or CFA.
Although differences have been found in the number of
sub-scales: 2 [8], 3 [12] or 4 [7,10]; close inspection shows
several similarities between the different outcomes. Themain difference between the various factor structures is
the placement of item 11 (“I get irritable when my feet
hurt.”). Previous analyses have placed this item in the foot
function scale [7,12], in the foot pain scale [10] and in a
combined pain and appearance scale [8]. In our opinion
item 11 is related to emotion due to foot pain and there-
fore should not be part of the foot function scale. In our
data it fits best with items 12 and 13 which were previ-
ously labelled as appearance items. These two items are
actually about feeling self-conscious about the appearance
of feet and shoes and do not mention the appearance itself
of feet and shoes. Adding item 11 to these two and nam-
ing it “perception scale” adds to the face-validity of the
scale in our opinion.
Reliability
Although internal consistency has been evaluated in
every MFPDI validation study published [7-12], only two
studies evaluated the IC per individual sub-scale [8,12].
Both studies found acceptable internal consistencies (>0.7)
for all tested sub-scales in contrast to our findings. Our
findings suggest that the functional scale is internally con-
sistent (0.84), the pain scale is just below acceptable (0.67)
and the internal consistency of the perception sub-scale is
moderate (0.60). The differences between our results and
those found by Cook et al. [8] (IC of the pain and appear-
ance scale: 0.75) could be explained by the differences in
the number of items; respectively 3 and 7 items. The
test-retest reliability of the foot function sub-scale is
almost acceptable (ICC = 0.69) but the reliability of the
pain sub-scale is moderate (0.49) and the reliability of
the perception sub-scale is poor (0.10). All participants
scored at least one item of the entire MFPDI as: “on
most/every day(s)” and our findings are consistent with
those reported by Roddy et al. [12]. A measurement
error has not been established before. Our findings sug-
gest that the SEM for the perception scale is too large;
36% of the possible maximum score.
Table 4 Results of measurement properties related to: responsiveness and interpretability
Measurement
property
Research question Method Dataset(s) Results Interpretation
Responsiveness Do change scores on




Pearsson Correlation* Comparator instruments:
FFI, NRS, SF12phys,
GPEpain and GPEfunction
The responsiveness of the
MFPDI is moderate; only 1 out
of 7 hypotheses was confirmed
and the correlation with the
GPE question is < 0.2.






after 3 months (NL T3)
1. R 0.31 (p < 0.000)
2. Correlation change
MFPDI-f and SF12
phys (R > 0.5)




3. R −0.46 (p < 0.000)
4. R hypothesis 1 > R
hypothesis 2.




5. R 0.37 (p < 0.000)
6. Correlation change
MFPDI-p and pain
NRS (R > 0.5)




7. R −0.47 (p < 0.000)
*A priori defined
hypothesis






MIC: NL T0, The correlation
coefficient between
the GPE and change
score is too low
to calculate a MIC
(R < 0.5).
The MFPDI is not responsive
enough to calculate a MIC.
NL T3
(1-specificity) n = 178
What is the Smallest
Detectable Change
(SDC)? And is the
MIC higher than the
SDC?
SDC SDC: NL T0 n = 205 SDC: The SDC for the perception
sub-scale is too large; the SDC











scored the two lowest
possible scores (0 or1)
per sub-scale.
Floor/ceiling effect: NL T0
n = 205
Floor/ceiling effects: The perception sub-scale




*MFPDI-f = MFPDI- function items, FFI-f = FFI- 5pts function items, SF-12 phys = SF12 physical function items, GPE-f = GPE-function question, MFPDI-p = MFPDI- pain
items, FFI-p = FFI- 5pts pain items, NRS-p = Pain Numeric Rating Scale, GPE-p = GPE-pain.
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The UK and Dutch participants differ on baseline on the
amount of foot related pain and dysfunction. However,
these differences are not of influence on the cross-
cultural validity analyses because item responses of UK
and Dutch patients with similar ‘true values’ are com-
pared to each other.
Assessment of the cross cultural validity by means of
DIF analysis showed that Dutch and UK participants
with a similar level of foot dysfunction complete the foot
function sub-scale in a similar manner. A small differ-
ence was found in the completion of the foot pain sub-scale. Assuming a similar ‘true value’ for foot related dis-
ability, the Dutch population has a higher probability of
endorsing the response option “none of the time’” or “on
some days” on item 17 as compared to the UK popula-
tion. We expect that the DIF of item 17 is due to the dif-
ference in location of the foot pain. The UK population
was included if they had pain in any part of the foot
whereas the Dutch population was selected when having
pain in the forefoot or toes. It is plausible that the char-
acteristics of forefoot pain might differ from the charac-
teristics of general foot pain explaining the difference
between the Dutch and UK population.
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firmed and thus the foot function and the pain scales
seem to be valid. Due to absence of a comparator instru-
ments the validity of the perception scale has not been
assessed. In a previous study by Menz et al. [10] the
MFPDI scores were compared to other patient reported
outcomes like the GADS depression sub-scale and the
SF-36 mental health and general health sub-scale. These
correlation coefficients were lower than those in our re-
sults; their highest correlation was R = 0.34. This is
probably due to the fact that the comparator instru-
ments differ in both studies and that the instruments
used in this study are more foot related. Even though
the construct validity is acceptable based on these find-
ings, we are hesitant about the face validity of the foot
pain scale. Previous authors have described this scale as
measuring pain intensity [7,11,12]. Examining the items
in this scale it is striking that none of the items actually
posses a reference to pain intensity. The items mainly
ask about when the foot pain is worse and about the
kind of pain. This scale also contains several opposing
statements. Item 15 states: “My feet are worse in the
morning” whilst item 16 states: “My feet are more pain-
ful in the evening”. Items 14 and 17 are somewhat op-
posing as well: “I have constant pain in my feet” versus I
have shooting pain in my feet”. We are hesitant to use
this sub-scale if pain intensity is the construct of
interest.
Responsiveness and interpretation
Neither responsiveness nor a MIC have previously been
established. Comparing the change scores of the foot
function and the pain sub-scale to changes in compara-
tor instruments like the foot function index-5 pt (foot
related activities and pain sub-scales), the SF12 physical
component and the pain NRS, only moderate correla-
tions were found. But most importantly, the correlation
between the change scores and anchor question (GPE
question) were only moderate (R = 0.43-0.47). We con-
sidered these correlation coefficients too low (below 0.5)
to calculate a MIC. There are multiple possible explana-
tions for the moderate responsiveness. With regard to
the entire questionnaire, it could be that the response
options (none of the time, on some days and on most/
every day(s)) are too widely spaced to be able to measure
small changes over time. With regard to the foot func-
tion sub-scale; the questionnaire uses items that clearly
begin with: ‘because of the pain in my feet…’. Even so,
the activities stated could very likely be influenced by
other variables like loss of muscle strength or pain in
other joints, especially within an older population. It
could possibly be hard to distinguish the inability to do
something because of foot pain or other pains and there-
fore it might not respond to change if only one of theproblems improves. The SDC is calculated based on the
SEM and so the perception scale has an extreme high
SDC; 5.8 points on a scale that has a 6 point maximum.
This sub-scale also has a large floor effect; 76.5% of the
participants have a score of 0 or 1 point. Combining
these two findings, it will be improbable to find a change
within this scale.
The main strength of this study is that the full array of
measurement properties based on CTT has been evalu-
ated. Nevertheless, the results of this study should be
interpreted in light of its limitations. The group of par-
ticipants used for this evaluation of the MFPDI (NL T0)
is very homogeneous; >50 years of age, visited their GP
with forefoot pain not due to rheumatoid arthritis or
skin lesions and no diabetic neuropathy. Particularly the
attribute of having forefoot pain is different compared to
other studies. Even though our results do not seem to
differ a lot from previously published work, measurement
properties like responsiveness, MIC, SDC and SEM have
not been assessed before. And thus it is unsure if, for in-
stance, the moderate responsiveness the MFPDI holds for
populations with other kinds of foot pain as well. Another
limitation is that the power in this study was insufficient
to assess DIF for variables like to age, gender and location
of foot pain.
Although foot pain in general is more common in
woman than in man [2,3]. The percentage of women
in this study (77.6%) differ from both gender distribu-
tions reported by Garrow et al. [2] (59.6%) or the UK
NOrStOP data (63%). These studies contain people
with foot pain in general. It could be that women are,
more so than men, predisposed to have forefoot prob-
lems, compared to pain anywhere in the foot. Never-
theless, most outcomes in this study are comparable
to those of other studies [9-12]. We therefore assume
that the difference in gender distribution does not
affect the outcome of this study.
Conclusion
Results using the Dutch version of the MFPDI are
not different from those using the English version
since the function scale has no DIF and the pain scale
only a small amount. Due to the limited reliability,
moderate responsiveness, floor effect and large meas-
urement error of both the pain and most of all the
perception scale, found in our study and other studies
it is advisable that the items in these scales (item 10-
17) are used with extreme caution. Quantifying pain
by the use of a NRS or VAS can be an alternative.
The reliability of the function scale (items 1-9) is ac-
ceptable as is its construct validity. The moderate re-
sponsiveness of the MFPDI function scale should be
taken into consideration when using it in a longitu-
dinal study. It is unclear if these results would be
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the forefoot or if the results are influenced by prob-
lems in the entire lower extremity.
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